Dietrich A. Volmer

Prof. Dr. Dietrich A. Volmer

Bioanalytical Chemistry, Institute of Chemistry, Humboldt-Universität zu Berlin, 12489 Berlin, Germany
orcid

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 October 2004 in Journal of Mass Spectrometry
Verified
Journal Article
Closed access
PDF file
LSLekha Sleno
Lekha Sleno
DVDietrich A. Volmer
Dietrich A. Volmer

13 February 2014 in The Analyst
Verified
Journal Article
Open access
PDF file
CBCaroline Bylda
Caroline Bylda
RTRoland Thiele
Roland Thiele
UKUwe Kobold
Uwe Kobold
DVDietrich A. Volmer
Dietrich A. Volmer
Liquid chromatography-mass spectrometry analysis of small molecules from biofluids requires sensitive and robust assays. Because of the very complex nature of many biological samples, efficient sample preparation protocols to remove unwanted components and to selectively extract the compounds of interest are an essential part of almost every bioanalytical workflow. This review describes the most common problems encountered during sample preparation, ways to optimize established sample preparation techniques and important recent developments to reduce or eliminate major interferents from biofluids.

1 January 2013 in The Analyst
Verified
Journal Article
Closed access
PDF file
DGDavid Gode
David Gode
DVDietrich A. Volmer
Dietrich A. Volmer
Mass spectrometry imaging (MSI) has proven to be extremely useful for applications such as the spatial analysis of peptides and proteins in biological tissue, the performance assessment of drugs in vivo or the measurement of protein or metabolite expression as tissue classifiers or biomarkers from disease versus control tissue comparisons. The most popular MSI technique is MALDI mass spectrometry. First invented by Richard Caprioli in the mid-1990s, it is the highest performing MSI technique in terms of spatial resolution, sensitivity for intact biomolecules and application range today. The unique ability to identify and spatially resolve numerous compounds simultaneously, based on m/z values has inter alia been applied to untargeted and targeted chemical mapping of biological compartments, revealing changes of physiological states, disease pathologies and metabolic faith and distribution of xenobiotics. Many MSI applications focus on lipid species because of the lipids' diverse roles as structural components of cell membranes, their function in the surfactant cycle, and their involvement as second messengers in signalling cascades of tissues and cells. This article gives a comprehensive overview of lipid imaging techniques and applications using established MALDI and SIMS methods but also other promising MSI techniques such as DESI.

28 December 2012 in Liver International
Verified
Journal Article
Open access
PDF file
CSCaroline S. Stokes
Caroline S. Stokes
DVDietrich A. Volmer
Dietrich A. Volmer
FGFrank Grünhage
Frank Grünhage
FLFrank Lammert
Frank Lammert
Chronic liver disease (CLD) and several related extrahepatic manifestations such as hepatic osteodystrophy are associated with deficiency of vitamin D, which has therefore been suggested as therapeutic target. Vitamin D undergoes hepatic 25‐hydroxylation, rendering the liver critical to the metabolic activation of this vitamin. Vitamin D deficiency is highly prevalent in CLD patients, and vitamin D levels are inversely related to the severity of CLD. Declining levels of carrier proteins such as albumin and vitamin D‐binding protein might also be critical in CLD. Intervention studies report improvements of CLD following supplementation, and benefits to health outcomes in particular with respect to hepatitis C virus infection have recently been documented.Content:We discuss vitamin D sources, functions and metabolism with a focus on the inherent complications of analytical measurements, such as the interference of 25‐hydroxyvitamin D and 1,25‐dihydroxyvitamin D C‐3 epimers. Global discrepancies in the definition of optimal serum 25‐hydroxyvitamin D levels are covered, and the prevalence of vitamin D deficiency in CLD is reviewed. We also address the functional mechanisms underlying this deficiency, and refer to associations between genetic variation in vitamin D metabolism and CLD. Lastly, we consider the health implications of a vitamin D deficiency in CLD and consider therapeutic options.Summary: Herein, we focus on the epidemiological and functional relationships between vitamin D deficiency and CLD, followed by a discussion of the potential implications for therapeutic interventions.

14 July 2010 in Analytical and Bioanalytical Chemistry
Verified
Journal Article
Open access
PDF file
SDShujing Ding
Shujing Ding
ISInez Schoenmakers
Inez Schoenmakers
KJKerry Jones
Kerry Jones
Albert KoulmanAlbert Koulman
Albert Koulman
APAnn Prentice
Ann Prentice
DVDietrich A. Volmer
Dietrich A. Volmer
Vitamin D is an important determinant of bone health at all ages. The plasma concentrations of 25-hydroxy vitamin D (25-OH D) and other metabolites are used as biomarkers for vitamin sufficiency and function. To allow for the simultaneous determination of five vitamin D metabolites, 25-OH D3, 25-OH D2, 24,25-(OH)2 D3, 1,25-(OH)2 D3, and 1,25-(OH)2 D2, in low volumes of human plasma, an assay using ultra-high-performance liquid chromatography–tandem mass spectrometry (UHPLC-MS/MS) was established. Plasma samples were spiked with isotope-labeled internal standards and pretreated using protein precipitation, solid-phase extraction (SPE) and a Diels–Alder derivatization step with 4-phenyl-1,2,4-triazoline-3,5-dione. The SPE recovery rates ranged from 55% to 85%, depending on the vitamin D metabolite; the total sample run time was <5 min. Mass spectrometry was conducted using positive ion electrospray ionization in the multiple reaction monitoring mode on a quadrupole–quadrupole-linear ion trap instrument after pre-column addition of methylamine to increase the ionization efficiency. The intra- and inter-day relative standard deviations were 1.6–4.1% and 3.7–6.8%, respectively. The limit of quantitation for these compounds was determined to be between 10 and 20 pg/mL. The 25-OH D results were compared with values obtained for reference materials (DEQAS). In addition, plasma samples were analyzed with two additional Diasorin antibody assays. All comparisons with conventional methods showed excellent correlations (r 2 = 0.9738) for DEQAS samples, demonstrating the high degree of comparability of the new UHPLC-MS/MS technique to existing methods.

1 October 1997 in Analytical Chemistry
Verified
Journal Article
Closed access
DVDietrich A. Volmer
Dietrich A. Volmer
BMBashir Mansoori
Bashir Mansoori
SLSteven J. Locke
Steven J. Locke